[1]
Khaskheli, S.A. and Rajpar, N.A. 2024. Semaglutide: an emerging treatment option for patients with obesity related HFpEF. Journal of the Pakistan Medical Association. 74, 9 (Aug. 2024), 1743–1743. DOI:https://doi.org/10.47391/JPMA.20158.